수동 소생기 시장 규모는 2024-2030년의 예측 기간 동안 CAGR 6.13%로 성장할 것으로 예측됩니다.
수동 소생기 시장은 심정지 및 만성 폐색성 폐 질환(COPD)과 같은 심폐 및 호흡기 질환의 발생률 증가와 같은 몇 가지 주요 요인에 의해 견인되고 있습니다. 또한 병원 밖에서의 심정지, 외상, 사고 발생률의 높이도 긴급용 수동 소생기의 요구를 높여가고 있습니다. 또한 노년 인구 증가와 세계 제조업체의 수동 소생기 신제품 및 개량품의 지속적인 전개도 예측 기간 동안 시장 성장을 뒷받침하고 있습니다.
Resuscitation Council UK가 제공한 최신 데이터에 따르면, 2021년 원외심정지(OHCA)의 연간 발생률은 인구 10만명당 약 55명이었습니다. 심정지의 대부분(72%)은 가정에서 발생하고, 또 15%는 직장에서 발생하고 있습니다. 심정지의 대부분(98%)은 성인에서 발생하며, 그 3분의 1(33%)은 15-64세입니다. 원내 심정지(IHCA)의 연간 발생률은 입원 환자 1,000명당 1-1.5명입니다. IHCA를 일으킨 사람의 평균 연령은 70세이며, 1/4(26.7%)은 16-64세입니다. 이와 같이, 원외 및 원내에서의 심정지의 발생률이 상승하고 있기 때문에 수동 소생기의 중요한 필요성이 부각되고 있습니다. 의료 제공업체, 응급대원 및 공중보건기구는 생존율과 환자 결과를 개선하는 데 점점 더 중점을 두고 있으며, 고품질의 수동 소생기 수요를 견인하고 있습니다. 게다가 의식 증가와 즉각적인 대응 능력에 대한 중요한 요구는 직접 수동 소생기에 대한 수요의 급증으로 이어져 시장 성장과 소생 기술 혁신에 박차를 가하고 있습니다.
또한 WHO의 최신 데이터(2023년)에 따르면 COPD 환자 수는 세계에서 3억 9,200만 명으로 추정되고 있습니다. 또한 Australian Institute of Health and Welfare가 제공한 데이터(2023년)에 따르면 COPD는 2023년 호흡기 질환 부담의 50%, 전 질환 부담에서는 3.6%를 차지하고 있습니다. COPD는 세계의 이환율과 사망률의 주요 원인이며, 종종 심각한 호흡 곤란과 급성 악화를 일으키고 급한 호흡기 지원이 필요합니다. COPD 환자가 증가함에 따라 긴급 상황에서 효율적이고 신뢰할 수 있는 산소 공급이 가능한 수동 소생기 수요도 증가하여 시장 전체를 밀어 올리고 있습니다.
이 보고서는 세계 수동 소생기 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법 규제 환경, 시장 규모 추이 및 예측, 각종 구분, 지역/주요 국가별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등을 정리했습니다.
Manual Resuscitators Market by Type (Self-Inflating and Flow-Inflating), Usage (Disposable and Reusable), Patient (Adults, Neonatal, and Pediatric), Application (Cardiopulmonary Obstructive Disorders (COPD), Cardiac Pulmonary Arrest, and Others), End-Users (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the growing prevalence of cardiopulmonary obstructive disorders (COPD), increasing prevalence of cardiac pulmonary arrest, and increasing awareness about resuscitation across the globe.
The manual resuscitators market is estimated to grow at a CAGR of 6.13% during the forecast period from 2024 to 2030. The market for manual resuscitators is driven by several key factors. The increasing incidence of cardiopulmonary and respiratory conditions, such as cardiac arrest and chronic obstructive pulmonary disease (COPD). Additionally, the high incidence of out-of-hospital cardiac arrests, trauma, and accidents also drives the need for emergency manual resuscitators. Further, the growing geriatric population and continuous introduction of new and improved manual resuscitators by manufacturers worldwide are propelling market growth during the forecast period from 2024 to 2030.
Manual Resuscitators Market Dynamics
According to the latest data provided by the Resuscitation Council UK (2021), in 2021, the annual incidence of out-of-hospital cardiac arrest (OHCA) was approximately 55 per 100,000 inhabitants. Most cardiac arrests (72%) occur in the home, with an additional 15% occurring in the workplace. The vast majority of cardiac arrests (98%) occur in adults, with one-third (33%) of these adults aged 15-64 years. The annual incidence of in-hospital cardiac arrest (IHCA) is 1 to 1.5 per 1,000 hospital admissions. The average age of individuals sustaining an IHCA is 70 years, with a quarter (26.7%) aged 16-64 years. Thus, the rising incidence of both out-of-hospital and in-hospital cardiac arrests underscored the critical need for manual resuscitators. Healthcare providers, emergency responders, and public health organizations are increasingly focused on improving survival rates and patient outcomes, driving the demand for high-quality manual resuscitators. Additionally, the heightened awareness and the critical need for immediate response capabilities directly translate into a surge in demand for manual resuscitators, fueling market growth and innovation in resuscitation technologies.
Additionally, as per the latest data provided by the World Health Organization (2023), it was estimated that there were 392 million cases of COPD globally. Furthermore, as per the data provided by the Australian Institute of Health and Welfare (2023), COPD accounted for 3.6% of the total disease burden from 50% of the burden of respiratory conditions in 2023. COPD, a leading cause of morbidity and mortality worldwide, often leads to severe respiratory distress and acute exacerbations that require immediate respiratory support. As the number of COPD patients rises, so does the demand for manual resuscitators which are capable of providing efficient and reliable oxygen during emergencies thereby boosting the overall market.
Additionally, the market is expected to see a boost from the approval of newly developed resuscitators. For instance, in October 2022, Laerdal Medical announced that its NeoNatalie Resuscitator received approval under the new EU Medical Device Regulation (MDR). Thus, the increasing product approvals and new launches boost the market for manual resuscitators by expanding reach, increasing product visibility, optimizing distribution, offering targeted sales and support, and creating market differentiation and competitive advantages.
However, the complications associated with manual resuscitators and the presence of alternative methods that provide respiratory support in emergencies may result in slight obstacles to the growth of the manual resuscitators market.
Manual Resuscitators Market Segment Analysis:
Manual Resuscitators Market by Type (Self-Inflating and Flow-Inflating), Usage (Disposable and Reusable), Patient (Adults, Neonatal, and Pediatric), Application (Cardiopulmonary Obstructive Disorders (COPD), Cardiac Pulmonary Arrest, and Others), End-Users (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the patient segment of the manual resuscitators market, the neonatal category is estimated to have a significant revenue share in the manual resuscitators market in 2023. The applications of neonatal resuscitators provide effective respiratory support tailored to the delicate needs of newborn infants. These resuscitators are designed to accommodate the unique physiology of newborns, including their smaller airways and respiratory requirements. Neonatal resuscitators are user-friendly and are often designed for ease of use in high-stress environments such as delivery rooms and NICUs. Neonatal resuscitators are boosting the overall resuscitator market more significantly due to the critical need for effective neonatal care. The specialized nature of these devices, coupled with increased awareness, regulatory support, and focused investments in neonatal healthcare infrastructure, drives their higher market demand and growth compared to other types of resuscitators.
Additionally, the rising number of preterm births, which often require respiratory support, further boosts the market for neonatal resuscitation devices. For instance, as per the latest data provided by the World Health Organization (2023), an estimated 13.4 million babies were born preterm in 2020. Furthermore, as per the data provided by the Pan America Health Organization (2023), of every 10 babies born, 1 is preterm and every 40 seconds, 1 of those babies dies across the world. The underdeveloped lungs of preterm infants are not fully equipped to handle the transition to breathing air outside the womb. As a result, many premature babies experience respiratory distress syndrome, thus the need for resuscitators in preterm infants is further increased thereby boosting the market of infant resuscitators and thus boosting the overall market of resuscitators.
Thus, due to the above-mentioned factors, the neonatal category is estimated to amass significant revenue, which will further in return boost the market for manual resuscitators during the forecast period.
North America Is Expected To Dominate The Overall Manual Resuscitators Market:
North America is expected to account for the highest proportion of the manual resuscitators market in 2023, out of all regions. The burgeoning market for manual resuscitators is underpinned by a complex interplay of factors, each contributing to its rapid expansion. Chronic obstructive pulmonary disease (COPD) and cardiac pulmonary arrest are significant health challenges that drive the demand for manual resuscitators in North America. COPD, affects millions of people in the region, leading to frequent exacerbations that require immediate respiratory support. Furthermore, the growing awareness and implementation of resuscitation education programs further enhances the market for manual resuscitators by emphasizing the importance of early intervention and proper resuscitation techniques.
According to recent data provided by the Heart and Stroke Statistics (2022), there were more than 356,000 out-of-hospital cardiac arrests (OHCA) annually in the U.S. The incidence of emergency medical services-assessed non-traumatic OHCA in people of any age is estimated to be 356,461, or nearly 1,000 people each day. Thus, the data serve as a compelling driver for the manual resuscitator market in the region. Healthcare providers, emergency responders, and public health organizations are increasingly recognizing the need for quick and effective intervention in cardiac arrest scenarios. This recognition is likely to spur investments in resuscitators that can enhance the chances of survival for cardiac arrest victims thereby boosting the market for manual resuscitators in the region.
As per the recent data provided by American Lung Association (2024) findings, approximately 1.7 million adults, constituting 4.6% of the adult population of the US, had reported a diagnosis of COPD, encompassing chronic bronchitis or emphysema. Notably, there was a higher prevalence of COPD among women than men, as well as among individuals aged 65 and older compared to younger age brackets. In conclusion, the rising prevalence of COPD in the US is anticipated to fuel the growth of the manual resuscitator market in the US, which will in return fuel the market growth for manual resuscitators in North America.
Thus, the above mentioned factors are expected to escalate the market of manual resuscitators in the region.
Manual Resuscitators Market Key Players:
Some of the key market players operating in the manual resuscitators market include Vyaire Medical Inc., Ambu A/S, Teleflex Inc., Zeal Medical Private Limited, Medline Industries Inc., Allied Healthcare, GE Healthcare, Drager Medical AG and Co., Laerdal Medical, Hopkins Medical Products, Mercury Medical, Cardinal Health, Bayer AG, McKesson Corporation, Romsons, and others.
Recent Developmental Activities In The Manual Resuscitators Market:
Key Takeaways From The Manual Resuscitators Market Report Study
Target Audience Who Can Be Benefited From This Manual Resuscitators Market Report Study
Frequently Asked Questions For The Manual Resuscitators Market:
Manual resuscitators, also known as bag-valve-mask (BVM) devices or self-inflating bags, are essential medical devices used to provide positive pressure ventilation to patients who are not breathing adequately or are in respiratory distress. These devices are commonly used in emergency and critical care settings, including hospitals, ambulances, and clinics.
The manual resuscitators market is estimated to grow at a CAGR of 6.13% during the forecast period from 2024 to 2030.
The market for manual resuscitators is driven by several key factors. The increasing incidence of cardiopulmonary and respiratory conditions, such as cardiac arrest and chronic obstructive pulmonary disease (COPD). Additionally, the high incidence of out-of-hospital cardiac arrests, trauma, and accidents also drives the need for emergency manual resuscitators. Further, the growing geriatric population and continuous introduction of new and improved manual resuscitators by manufacturers worldwide are propelling market growth during the forecast period from 2024 to 2030.
Some of the key market players operating in the manual resuscitators are Vyaire Medical Inc., Ambu A/S, Teleflex Inc., Zeal Medical Private Limited, Medline Industries Inc., Allied Healthcare, GE Healthcare, Drager Medical AG and Co., Laerdal Medical, Hopkins Medical Products, Mercury Medical, Cardinal Health, Bayer AG, McKesson Corporation, Romsons, and others.
North America is expected to account for the highest proportion of the manual resuscitators market in 2023, out of all regions. The rising prevalence of chronic obstructive pulmonary disease (COPD) and cardiac pulmonary arrest is a major driver boosting the demand for manual resuscitators in North America. Furthermore, the growing awareness and implementation of resuscitation education programs enhance the market for manual resuscitators by emphasizing the importance of early intervention and proper resuscitation techniques.